Abstract: A covering device includes an elongate wrapping member configured to be wrapped around and overlay an opening in an object in a wrapped condition, a substantially shell-shaped cover member for covering the wrapping member substantially in the wrapped condition, and a retaining arrangement for retaining the cover member and with it, the wrapping member in position relative the object in a covering condition.

Abstract: An embodiment of the present invention relates to a composite structure with one or several polyurethane layers, which is substantially free of volatile organic compounds (VOC). In addition, the invention relates to the method of manufacturing such composite structure. Further, the invention relates to the use of such composite structure, in particular as artificial leather.

Abstract: A covering device includes an elongate wrapping member configured to be wrapped around and overlay an opening in an object in a wrapped condition, a substantially shell-shaped cover member for covering the wrapping member substantially in the wrapped condition, and a retaining arrangement for retaining the cover member and with it, the wrapping member in position relative the object in a covering condition.

Abstract: A sealing device for sealing a leak in a pipe includes an elongate pipe wrapping member which is configured to be wrapped around and overlay a leak in a pipe in a wrapped condition a cover member for covering the pipe wrapping member substantially in the wrapped condition and a retaining arrangement for retaining the cover member and with it, the pipe wrapping member in position relative the pipe in a pipe sealing condition.

Abstract: A sealing device for sealing a leak in a pipe includes an elongate pipe wrapping member which is configured to be wrapped around and overlay a leak in a pipe in a wrapped condition a cover member for covering the pipe wrapping member substantially in the wrapped condition and a retaining arrangement for retaining the cover member and with it, the pipe wrapping member in position relative the pipe in a pipe sealing condition.

Abstract: The present invention relates to a storage and dispensing system for products and/or packagings. The system (1) comprises at least one carrier (3) with at least a bottom (34) which defines thereon a space for the products and/or packagings, a storage area (2), such as a storage rack or shelving system, for selectively accommodating the carrier, and at least one transporter (4) for selective displacement of the carrier from and/or to and into and/or out of the storage area. In a situation where it is accommodated in the storage area the carrier comprises a gripping element (31) on a side oriented outside the storage area, and the transporter comprises a gripping device (23) acting on the gripping element at least during displacement of the carrier into and/or out of the storage area. Space can thus be saved in the storage area laterally of carriers placed therein, and a compact configuration of the storage area can be realized.

Abstract: The invention relates to a process for the preparation of a freeze-dried fruit of Parkia, preferably Parkia speciosa comprising the steps of a) freezing a fruit, preferably beans from Parkia to ?20° C. or below to obtain a frozen fruit and b) subsequently freeze-drying the frozen fruit by reducing the pressure surrounding the said frozen fruit to allow water and volatiles to sublimate and/or evaporate from the frozen fruit to obtain the freeze-dried fruit of Parkia, wherein the temperature of the fruit during freeze-drying is at most 0° C., wherein the temperature of the fruit from the beginning of step a) until the end of step b) does not exceed 30° C. The invention also relates to the products obtained with the process, including their use as a medicament in the treatment, co-treatment and/or prevention of diabetes mellitus and/or for weight regulation.

Abstract: The invention provides a method to effectively wean a woman from hormonal therapy for treatment of vasomotor symptoms by reducing the dosage of the hormonal agent to zero, while a non-hormonal drug in an amount, which is therapeutically effective for treating vasomotor symptoms, is administered or initiated and continued for one or more periods of durations determined by assessment of the effect of a treatment free period, which follows each period of continuous non-hormonal drug treatment.

Abstract: An improved wound dressing using a honey composition is provided. Preferably, the honey composition includes buckwheat honey.

Abstract: Reactive oxygen species associated with a wound are modulated through treatment of the wound with a solution of metal ions selected from the group consisting of potassium ions, zinc ions, calcium ions and rubidium ions, at a pH of between about 5 and about 7. Preferably, citric acid is employed to adjust the pH of the solution. Application of the extract to a wound exhibiting superoxide anions has been found to be effective in the treatment of these wounds through the reduction of the level of superoxide anions. Moreover, treatment of partial thickness excision wounds as well as contact burn wounds with the present composition has been found to improve epithelialization of these wounds. In addition to the antioxidant activity of the present invention, treatment of the wound employing the present composition produces inhibitory effects on ROS production by human PMNs and on human complement activation, and therefore, is further beneficial in chronic wound management.

Abstract: The invention provides a method to effectively wean a woman from hormonal therapy for treatment of vasomotor symptoms by reducing the dosage of the hormonal agent to zero, while a non-hormonal drug in an amount, which is therapeutically effective for treating vasomotor symptoms, is administered or initiated and continued for one or more periods of durations determined by assessment of the effect of a treatment free period, which follows each period of continuous non-hormonal drug treatment.

Abstract: A communication system (1) for example a voice and/or data system, has at least one user terminal (T1 . . . Tn), a facility providing processing device (2) coupled thereto for connecting the user terminals (T1 . . . Tn), and an intervening network (3) for interconnection of the processing device (2) and a remote user terminal (RT1 . . . RTm). The intervening network (3) is arranged for conveying at least facility related signals (S), and the processing device (2) is equipped for allowing its facilities to be used by the remote user terminal (RT1 . . . RTm). An appropriate signalling protocol, such as with DTMF tones can be used to communicate the facility related signals (S) through the intervening network (3), between the processing device (2) and the remote user termnal (RT1 . . . RTm).

Abstract: Novel methods and novel industrial unicellular microorganism strains, particularly industrial Bacillus strains, are provided for enhanced production of endogenous and exogenous polypeptides. Cloning vehicles containing the gene expressing the polypeptide of interest are introduced into a compatible host. Transformed hosts harboring the introduced vehicle in a stable way by integration of the vehicle into the host cells chromosome are selected. Efficient transfer of the vehicle containing the gene of interest is achieved with the resulting industrial strain transformants being effective, stable producers of the desired polypeptide product.

Abstract: Novel methods and novel industrial unicellular microorganism strains, particularly industrial Bacillus strains, are provided for enhanced production of endogenous and exogenous polypeptides. Cloning vehicles containing the gene expressing the polypeptide of interest are introduced into a compatible host. Transformed hosts harboring the introduced vehicle in a stable way by integration of the vehicle into the host cells chromosome are selected Efficient transfer of the vehicle containing the gene of interest is achieved, with the resulting industrial strain transformants being effective, stable producers of the desired polypeptide product.

Abstract: A new cloning system is described capable of expressing genetic material derived from recombinant DNA material, which comprises a yeast of the genus Kluyveromyces as a host. Suitable vectors are e.g. vectors containing autonomously replicating sequences (ARS) and vectors containing homologous Kluyveromyces DNA acting as a site for recombination with the host chromosome. New and preferred vectors are those containing ARS sequences originating from Kluyveromyces (KARS vectors). The genetically engineered new strains of Kluyveromyces produce, inter alia, lactase and chymosin.

Abstract: The invention relates to yeasts of the genus Kluyveromyces, in particular K. lactis, acting as hosts for the expression of preprothaumatin or its various allelic and modified forms or their maturation forms, which yeasts contain an rDNA plasmid comprising a structural gene encoding for a thaumatin-like protein, an autonomous replicating sequence derived from K. lactis (KARS), a yeast regulon derived from the GAPDH-genes of S. cerevisiae, and a selection marker, e.g. the trp-1 or the lac-4 gene from S. cerevisiae and K. lactis, respectively. Optionally the plasmid also contains a transcription terminator from a yeast. Further the preparation of such yeasts and the preparation of thaumatin-like proteins with such yeasts and the proteins so obtained are claimed. The yeast described give a better expression than obtained with E. coli as described in EP-PA (A2) 0 054 330 and 0 054 331, published on June 23, 1982.